Sodium Monofluorophosphate Toothpaste for Gum Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a toothpaste containing sodium monofluorophosphate to evaluate its effectiveness in reducing plaque and improving gum health in individuals with gingivitis. Researchers aim to understand its effects on both mild and severe gum inflammation. The trial seeks participants with high plaque levels who regularly experience gum inflammation. Individuals with at least 20 natural teeth and frequent gum bleeding may find this trial suitable. As a Phase 4 trial, this research involves an FDA-approved treatment and aims to understand its benefits for a broader patient population.
Will I have to stop taking my current medications?
The trial requires that you stop using antibiotics, antimicrobial drugs, anti-inflammatory drugs, or anticoagulant therapies at least 30 days before starting the study. If you are using any of these medications, you will need to stop them before participating.
What is the safety track record for sodium monofluorophosphate toothpaste?
A previous study found that using sodium monofluorophosphate toothpaste daily is safe for oral health, with no harmful effects on oral bacteria. The FDA has already approved this toothpaste for use in other oral health products, indicating it is generally well-tolerated. Based on available research, sodium monofluorophosphate toothpaste appears safe for managing gum disease.12345
Why are researchers enthusiastic about this study treatment?
Most treatments for gum disease focus on reducing plaque and inflammation using standard fluoride toothpastes. However, sodium monofluorophosphate toothpaste is unique because it combines fluoride with phosphate, which not only fights cavities but also provides enhanced protection for the gums. Researchers are excited about this treatment because the phosphate component may help strengthen tooth enamel and improve overall gum health, potentially offering a dual-action benefit that standard fluoride toothpastes do not.
What is the effectiveness track record for sodium monofluorophosphate toothpaste in treating gum disease?
This trial will compare the effects of brushing with sodium monofluorophosphate toothpaste to sodium fluoride toothpaste for gum disease. Research has shown that sodium monofluorophosphate toothpaste primarily fights cavities but does not directly affect the bacteria causing gum disease. While it helps prevent tooth decay, it does not specifically target gum disease. In contrast, stannous fluoride reduces plaque and gingivitis, making it more suitable for gum problems. Sodium fluoride is more effective at preventing cavities than treating gum disease. The effectiveness of sodium monofluorophosphate for gum disease is less supported compared to other types of fluoride, such as stannous fluoride.12346
Who Is on the Research Team?
Gabriella John, MS
Principal Investigator
Colgate Palmolive
Are You a Good Fit for This Trial?
This study is for people who have a lot of dental plaque, with or without significant gum inflammation (gingivitis). Participants should not have conditions or factors that would prevent them from safely joining the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo oral examinations, gingival crevicular fluid collection, saliva collection, plaque collection, and complete questionnaires
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- sodium monofluorophosphate toothpaste
Trial Overview
Researchers are collecting and analyzing dental plaque and oral health data in people using sodium monofluorophosphate toothpaste. The focus is on comparing those with high plaque but different levels of gingivitis.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Colgate Palmolive
Lead Sponsor
Noel Wallace
Colgate Palmolive
Chief Executive Officer since 2019
MBA from Harvard Business School
Diana Haussling
Colgate Palmolive
Chief Marketing Officer since 2022
Bachelor's degree in Marketing
Citations
Toothpaste for Gum Disease · Info for Participants
Studies have shown that toothpaste with stannous fluoride (SnF2), included in the positive control arm of this trial, effectively reduces gum disease and plaque ...
Potential of Stannous Fluoride Toothpaste to Reduce Gum ...
This study will evaluate the efficacy of a dentifrice containing 0.454% weight by weight (w/w) stannous fluoride to control gingivitis and gingival bleeding ...
3.
greaterbostondentist.com
greaterbostondentist.com/blog/which-toothpaste-is-best-for-gum-disease-stannous-or-sodium-fluoride/Which toothpaste is best for gum disease prevention ...
Sodium fluoride will fight cavities only – it has no effect on gum disease bacteria – and will not stain your teeth. Remember: All over-the- ...
Impact of toothpaste use on the subgingival microbiome - PMC
The daily use of a CPC/cymenol toothpaste was microbiologically safe, with no negative effects on the composition of the subgingival microbiome.
A 6-Month Randomized Controlled Trial to Measure the ...
The test SnF2 dentifrice showed statistically significant reductions in all plaque and gingivitis indices compared to baseline and to the ...
6.
haleonhealthpartner.com
haleonhealthpartner.com/en-us/oral-health/brands/sensodyne/products/sensitivity-gum-toothpaste/Sensodyne: Sensitivity & Gum Toothpaste
40% improvement in gum health* ... *Percentage improvement in Bleeding Index after 24 weeks, test 0.454% w/w stannous fluoride toothpaste vs. control sodium ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.